PRESCRIBING: BONA FIDE RELATIONSHIP                                               H.B. 5678 (H-1):

                                                                                                    SUMMARY OF BILL

                                                                                      REPORTED FROM COMMITTEE

House Bill 5678 (Substitute H-1 as reported without amendment)

Sponsor:  Representative Bronna Kahle

House Committee:  Health Policy

Senate Committee:  Health Policy

CONTENT

The bill would amend the Public Health Code's definition of "bona fide prescriber-patient relationship" for purposes of prescribing a Schedule 2 to 5 controlled substance, to allow the delegation of a patient's medical evaluation.

The Code sets forth requirements for a licensed prescriber who prescribes a controlled substance. Beginning March 31, 2018, a prescriber must not prescribe a controlled substance listed in Schedule 2 to 5 unless the prescriber is in a bona fide prescriber-patient relationship with the patient for whom the controlled substance is being prescribed, except as otherwise provided by rules promulgated by the Department of Licensing and Regulatory Affairs.

The bill would include in the Code's definition of "bona fide prescriber-patient relationship" a relevant medical evaluation of the patient conducted by an individual licensed under Article 15 (Occupations) of the Code to whom the prescriber has delegated the authority to perform the evaluation.

MCL 333.7303a                                                       Legislative Analyst:  Stephen Jackson

FISCAL IMPACT

The bill would have no fiscal impact on State or local government.

Date Completed:  3-21-18                                         Fiscal Analyst:  Elizabeth Raczkowski

This analysis was prepared by nonpartisan Senate staff for use by the Senate in its deliberations and does not constitute an official statement of legislative intent.